Results 11 to 20 of about 44,049 (242)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective [PDF]

Microorganisms, 2020
Vulvovaginal candidiasis (VVC) is a widespread vaginal infection primarily caused by Candida albicans. VVC affects up to 75% of women of childbearing age once in their life, and up to 9% of women in different populations experience more than three ...
Diletta Rosati, Mariolina Bruno, M. Jaeger, J. ten Oever, M. Netea   +4 more
semanticscholar   +7 more sources

Sertaconazole in the treatment of vulvovaginal candidiasis

Медицинский совет, 2019
Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease.
Z. N. Efendieva
doaj   +4 more sources

Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection. [PDF]

Heliyon
Wang Y, Liu Z, Chen T.
europepmc   +2 more sources

Insights and advances in recurrent vulvovaginal candidiasis. [PDF]

PLoS Pathog, 2023
San Juan Galán J, Poliquin V, Gerstein AC.   +2 more
europepmc   +4 more sources

Vulvovaginal candidiasis [PDF]

Obstetrics and Gynecology Clinics of North America, 2003
VVC represents a spectrum of disease. Although there is a clear need for better use of diagnostic modalities and development of better treatment alternatives, most patients with VVC, even the complicated cases, at least have the perspective of achieving adequate control of their symptoms.
Paul, Nyirjesy, Jack D, Sobel
openaire   +7 more sources

Clinicomycological study of vulvovaginal candidiasis [PDF]

Indian Journal of Sexually Transmitted Diseases and AIDS, 2021
Background: Vaginal candidiasis is one of the most common vaginal infections in women of reproductive age group caused by Candida species of fungi, a normal inhabitant of vagina. Aims: The aim is to study the culture characteristics, species prevalence, and drug sensitivity of ...
P Nirmaladevi, M Selvakumar, S Seeniammal   +2 more
openaire   +3 more sources

Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy

Frontiers in Cellular and Infection Microbiology, 2023
Vaginal microbiome is mutually beneficial to the host and has a significant impact on health and disease. Candida species, including Candida albicans, are part of the mucosal flora of most healthy women.
Zhongwen Sun, Xinnuo Ge, B. Qiu, Ze Xiang, Chun Jiang, Jian Wu, Yuan Li   +6 more
semanticscholar   +1 more source

Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature

Journal of Obstetrics and Gynaecology Research, 2023
At concentrations achieved following systemic administration, the primary effect of imidazoles and triazoles on fungi is inhibition of 14-α-sterol demethylase, a microsomal cytochrome P450 (CYP) enzyme. Imidazoles and triazoles impair the biosynthesis of
P. Regidor, Manopchai Thamkhantho, Chenchit Chayachinda, S. Palacios   +3 more
semanticscholar   +1 more source

Increased vulvovaginal candidiasis incidence risk in various gestational ages at a private midwifery practice in Surabaya, Indonesia

Majalah Obstetri dan Ginekologi, 2022
HIGHLIGHTS 1. Hormonal changes during pregnancy lead to the presence of vulvovaginal candidiasis. 2. Increased incidence of vulvovaginal candidiasis in different pregnancy trimesters were analyzed. 3.
Regina Martina Cilik, Willy Sandhika, Zakiyatul Faizah   +2 more
doaj   +1 more source

Vaginal Transcriptional Signatures of the Neutrophil-Driven Immune Response Correlate With Clinical Severity During Recurrent Vulvovaginal Candidiasis. [PDF]

Am J Reprod Immunol
ABSTRACT Problem Recurrent vulvovaginal candidiasis (RVVC) affects 5%−10% of all women, negatively impacting their reproductive health and quality of life. Herein, we investigated the molecular effects of RVVC on the vaginal mucosa of otherwise healthy women.
Hasselrot T, Alvendal C, Hunt S, Boger MF, Kaldhusdal V, Damdimopoulos A, Schuppe-Koistinen I, Edfeldt G, Bohm-Starke N, Broliden K.   +9 more
europepmc   +2 more sources